Pages that link to "Q43657688"
Jump to navigation
Jump to search
The following pages link to The role of Smad3 in mediating mouse hepatic stellate cell activation (Q43657688):
Displaying 50 items.
- Enteric dysbiosis associated with a mouse model of alcoholic liver disease (Q24863915) (← links)
- Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects (Q26775055) (← links)
- Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis (Q26779846) (← links)
- Extracellular matrix and liver disease (Q26823060) (← links)
- Myofibroblasts and mechano-regulation of connective tissue remodelling (Q28216468) (← links)
- Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets (Q28303698) (← links)
- Predicting in vivo anti-hepatofibrotic drug efficacy based on in vitro high-content analysis (Q28477748) (← links)
- Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice (Q28552427) (← links)
- Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization (Q28567374) (← links)
- Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats (Q28571978) (← links)
- Liver fibrosis (Q29547449) (← links)
- Ginkgo biloba extract alleviates liver fibrosis induced by CCl in rats (Q33229156) (← links)
- Role of NADPH oxidases in liver fibrosis (Q33632736) (← links)
- Endoglin in liver fibrogenesis: Bridging basic science and clinical practice (Q33728841) (← links)
- Smad3 signaling in the regenerating liver: implications for the regulation of IL-6 expression (Q33756827) (← links)
- Smad3 knock-out mice as a useful model to study intestinal fibrogenesis (Q34013157) (← links)
- Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway (Q34218427) (← links)
- Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats (Q34414756) (← links)
- Mutation of the 5'-untranslated region stem-loop structure inhibits α1(I) collagen expression in vivo (Q34624521) (← links)
- Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis (Q34747455) (← links)
- Regulation of transforming growth factor-β1-dependent integrin β6 expression by p38 mitogen-activated protein kinase in bile duct epithelial cells (Q34868170) (← links)
- Liver fibrosis -- from bench to bedside (Q35068035) (← links)
- Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali (Q35087770) (← links)
- Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma (Q35102837) (← links)
- Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model (Q35112180) (← links)
- Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair (Q35124593) (← links)
- Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis (Q35405665) (← links)
- Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice (Q35481673) (← links)
- Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells (Q35649316) (← links)
- Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats (Q35744613) (← links)
- Smad3 as a mediator of the fibrotic response (Q35779047) (← links)
- Role of Fibroblast Growth Factor Type 1 and 2 in Carbon Tetrachloride-Induced Hepatic Injury and Fibrogenesis (Q35792203) (← links)
- Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice (Q35795593) (← links)
- Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury (Q35837968) (← links)
- Decorin-TGFβ axis in hepatic fibrosis and cirrhosis (Q35956255) (← links)
- Antifibrotic therapy in chronic liver disease (Q36036857) (← links)
- Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines (Q36100069) (← links)
- Cell signals influencing hepatic fibrosis (Q36220879) (← links)
- Prevention of TGF-β-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation (Q36338112) (← links)
- Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis (Q36371664) (← links)
- NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis (Q36524368) (← links)
- Transcriptional regulation of stellate cell activation (Q36588242) (← links)
- Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis (Q36698776) (← links)
- Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis (Q36717858) (← links)
- Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. (Q36736835) (← links)
- Inhibitory effect of bone morphogenetic protein-7 on hepatic fibrosis in rats (Q36800325) (← links)
- Divergent transforming growth factor-beta signaling in hepatic stellate cells after liver injury: functional effects on ECE-1 regulation (Q36855682) (← links)
- Liver fibrosis: possible involvement of EMT. (Q36857873) (← links)
- Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses. (Q37021754) (← links)
- Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis (Q37023975) (← links)